Advertisement

More articles from Companion Diagnostics and Biomarkers

  • UNG Determines Lung Cancer Sensitivity to Pemetrexed
    Lachelle D. Weeks, Pingfu Fu, Stanton L. Gerson
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2248-2260; DOI: 10.1158/1535-7163.MCT-13-0172
  • LMTK3 and Gastric Cancer
    Takeru Wakatsuki, Melissa J. LaBonte, Pierre O. Bohanes, Wu Zhang, Dongyun Yang, Mizutomo Azuma, Afsaneh Barzi, Yan Ning, Fotios Loupakis, Siamak Saadat, Nico Volz, Sebastian Stintzing, Rita El-Khoueiry, Wasaburo Koizumi, Masahiko Watanabe, Manish Shah, Justin Stebbing, Georgios Giamas, Heinz-Josef Lenz
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2261-2272; DOI: 10.1158/1535-7163.MCT-12-1134
  • BCL-2 Hypermethylation in Breast Cancer
    Andrew Stone, Mark J. Cowley, Fatima Valdes-Mora, Rachael A. McCloy, C. Marcelo Sergio, David Gallego-Ortega, C. Elizabeth Caldon, Christopher J. Ormandy, Andrew V. Biankin, Julia M.W. Gee, Robert I. Nicholson, Cristin G. Print, Susan J. Clark, Elizabeth A. Musgrove
    Molecular Cancer Therapeutics Sep 2013, 12 (9) 1874-1885; DOI: 10.1158/1535-7163.MCT-13-0012
  • Apoptotic CTCs in Breast Cancer
    Galatea Kallergi, Georgios Konstantinidis, Harris Markomanolaki, Maria A. Papadaki, Dimitris Mavroudis, Christos Stournaras, Vassilis Georgoulias, Sofia Agelaki
    Molecular Cancer Therapeutics Sep 2013, 12 (9) 1886-1895; DOI: 10.1158/1535-7163.MCT-12-1167
  • EGFR Exon 20 Insertions in Lung Cancer
    Maria E. Arcila, Khedoudja Nafa, Jamie E. Chaft, Natasha Rekhtman, Christopher Lau, Boris A. Reva, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi
    Molecular Cancer Therapeutics Feb 2013, 12 (2) 220-229; DOI: 10.1158/1535-7163.MCT-12-0620
  • Preclinical Study of T-3256336, a Selective IAP Antagonist
    Hiroyuki Sumi, Masato Yabuki, Kenichi Iwai, Megumi Morimoto, Ryosuke Hibino, Masakazu Inazuka, Kentaro Hashimoto, Yohei Kosugi, Kazunobu Aoyama, Shunsuke Yamamoto, Mie Yoshimatsu, Hideki Yamasaki, Ryuichi Tozawa, Tomoyasu Ishikawa, Sei Yoshida
    Molecular Cancer Therapeutics Feb 2013, 12 (2) 230-240; DOI: 10.1158/1535-7163.MCT-12-0699